Skip to content
SEARCH icon
  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
Search

SEARCH FOR AN ARTICLE

  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
icon

      HomeBiotech

      Biotech

      Global Multiomics Market Expected to Grow Rapidly, with 13.5% Annual Increase from 2024 to 2029
      Biotech

      Global Multiomics Market Expected to Grow Rapidly, with 13.5% Annual Increase from 2024 to 2029

      December 25, 2024
      FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes
      Biotech

      FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes

      December 24, 2024
      FDA Approves First Medication for Obstructive Sleep Apnea
      Biotech

      FDA Approves First Medication for Obstructive Sleep Apnea

      December 23, 2024
      FDA Roundup: December 20, 2024
      Biotech

      FDA Roundup: December 20, 2024

      December 22, 2024
      Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses
      Biotech

      Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses

      December 21, 2024
      Astraveus Secures €7.1M Non-dilutive Funding from the French State
      Biotech

      Astraveus Secures €7.1M Non-dilutive Funding from the French State

      December 20, 2024
      Ottimo Pharma Raises over $140 Million in Series A Financing
      Biotech

      Ottimo Pharma Raises over $140 Million in Series A Financing

      December 19, 2024
      U.S. FDA approves Celltrion’s STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab)
      Biotech

      U.S. FDA approves Celltrion’s STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab)

      December 18, 2024
      Innovative Medicines Canada Applauds Premiers’ Agreement at 2024 Council of the Federation Meeting to Accelerate Access to Life-Saving Medications
      Biotech

      Innovative Medicines Canada Applauds Premiers’ Agreement at 2024 Council of the Federation Meeting to Accelerate Access to Life-Saving Medications

      December 17, 2024
      Immunovia to host a webcast with the opportunity to learn more about the positive clinical validation of its next-generation pancreatic cancer test
      Biotech

      Immunovia to host a webcast with the opportunity to learn more about the positive clinical validation of its next-generation pancreatic cancer test

      December 16, 2024
      « 1 … 37 38 39 40 41 … 56 »

       

      LATEST NEWS

      • Investing Best Dividend Stock if the Bank of Canada Cuts Rates
      • Investing News Can This Undervalued Stock Make You a Millionaire?
      • Investing News High Dividend Yield Stocks for Passive Income: Fiera Capital
      • Investing Top Canadian ETFs to Buy and Hold in Your TFSA

      Trading Whisperer

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Trading Whisperer.

      I want e-mail alerts, updates, and offers and agree to the Trading Whisperer privacy policy.

      Market Jar Media Inc. © 2026